💊
Home›Clinicians›Webster Pack & DAA Reference

Webster Pack & DAA Reference

Practical GP reference on Dose Administration Aids (DAA / Webster packs) in Australia — when to consider, patient eligibility for funded packs, GP role in the medication review pathway, PBS cost implications.
When to consider
Access & funding
GP MBS pathway
Practical tips
Related tools
🎯
Clinical situations where a DAA typically helps
›
Common indications
  • Polypharmacy (typically ≥5 regular medicines)
  • Cognitive impairment or dementia — mild to moderate, where visual layout of the pack still provides useful cueing
  • Vision impairment affecting label reading
  • Reduced manual dexterity (arthritis, tremor, post-stroke)
  • Confusion about complex regimens (multiple daily doses, split doses)
  • Carer administering medication for someone else
  • Recent hospital discharge with a changed regimen
  • History of medication misadventure or non-adherence
  • Patient or family request after a near-miss
⚠️ A DAA is not a substitute for capacity assessment. If the patient cannot safely self-administer even with a DAA, consider carer administration, community nurse support, or higher level of care.
🚫
When a DAA may not be suitable
›
Medicines that generally can't be packed
  • Effervescent, dispersible, or sublingual tablets
  • Cytotoxic medicines
  • Hygroscopic tablets (e.g. sodium valproate immediate-release)
  • Medicines requiring refrigeration
  • Liquid preparations, patches, inhalers, injections
  • Some slow-release preparations depending on formulation
  • Warfarin (variable dosing — usually packed only if dose stable)
  • PRN medicines (kept separately, patient to take as needed)
Patient factors that reduce benefit
  • Frequent dose changes (regimen unstable)
  • Severe cognitive impairment where patient cannot open pack or recognise the visual cues
  • Behavioural concerns (removes and stockpiles medicines)
  • Non-adherence driven by belief or preference rather than practical difficulty
💡 If regimen keeps changing, consider stabilising first, then pack. Frequent re-packing is expensive for the pharmacy and disruptive for the patient.
💰
DAA Program — pharmacist funding pathway
›
Pharmacy Programs Administrator
What it funds The DAA Program funds community pharmacies (not GPs, not patients directly) to provide packing services to eligible patients living in the community. Pharmacies claim per service; patient pays no packing fee if eligible.
Typical patient eligibility
  • Living at home (not in a residential aged care facility)
  • Holds a current concession card OR is on 5 or more regular PBS medicines
  • Community pharmacist confirms clinical need
Each pharmacy has a cap on funded services per week under the program.
💡 If your patient doesn't meet DAA Program eligibility, packing is still available but the patient pays a weekly fee directly to the pharmacy — varies by pharmacy, typically $5–15/week.
Residential aged care For RACF residents, DAA packing is funded through the residential aged care medication management framework (not the community DAA Program). This is arranged by the facility with their supplying pharmacy — GPs generally don't need to arrange it.
Source: Pharmacy Programs Administrator DAA Program rules (ppaonline.com.au). Verify current eligibility with the patient's community pharmacist.
🛒
PBS cost impact for packed medicines
›
PBS
Key point A DAA does not change the PBS co-payment for medicines inside. The patient still pays the normal general or concession co-payment per script.
Practical note on brand substitution When medicines are re-packed weekly, the brand may vary if the pharmacy substitutes generics. This can confuse patients used to a particular tablet appearance. If brand consistency matters (visual identification, patient anxiety about "different" tablets), consider marking "brand substitution not permitted" on the script where clinically appropriate — but this may increase cost if the preferred brand attracts a brand price premium.
PBS Cost Calculator → MedCost Finder (compare brands) →
📋
MBS Item 900 — HMR / DMMR (community patients)
›
MBS 900 · $185.35
What it is GP referral to a credentialed pharmacist for a Home Medicines Review (HMR, also called DMMR). Reviews all medicines in the patient's home — prescription, OTC, supplements, complementary. Includes review of storage, adherence, and administration aids.
When to consider before / alongside a DAA
  • Polypharmacy where the goal is to simplify the regimen before packing
  • Frequent hospitalisations or medication-related presentations
  • Recent regimen change with concerns about tolerance or interactions
  • Uncertainty about which medicines the patient is actually taking
  • Patient or carer confusion about the purpose or timing of medicines
Follow-up services (from 2020) Up to 2 remunerated follow-up services within 9 months of the initial HMR — for the pharmacist to check on the medication management plan, adherence, and outcomes. GP does not need to re-refer for these.
Eligibility interval A subsequent HMR generally requires 24 months since the last, unless there is a significant change in condition or medication management plan.
⚠️ From 1 July 2027, DMMR eligibility will require a GP chronic condition management plan (GPCCMP). Plan ahead for patients likely to need reviews.
Full HMR/DMMR/RMMR guide →
Source: MBS Item 900 (mbsonline.gov.au). PPA HMR Program Rules. MBS Book July 2026.
🏥
MBS Item 903 — RMMR (RACF residents)
›
MBS 903 · $126.90
What it is GP participation in a Residential Medication Management Review for a resident of an aged care facility. GP must personally attend the resident as part of the review, and collaborate with the reviewing pharmacist.
Eligibility interval Once per 12 months, unless there is a significant change in condition or medication management plan.
Related items Item 249 — same purpose, claimed by Prescribed Medical Practitioners (not vocationally registered GPs).
Full HMR/RMMR guide →
Source: MBS Item 903 (mbsonline.gov.au). MBS Book July 2026.
📝
GPCCMP (MBS 965) — chronic condition plan
›
MBS 965 · $160.60
Why relevant to Webster packs A GP Chronic Condition Management Plan supports quality use of medicines. Many patients requiring a DAA also qualify for a GPCCMP. Documenting the medication management strategy in the plan supports the case for a DAA and unlocks up to 5 subsidised allied health services per year (e.g. dietitian, exercise physiologist, podiatrist for foot care in diabetes).
Practice nurse follow-up Item 93201 allows a practice nurse or Aboriginal and Torres Strait Islander health practitioner to provide follow-up services on behalf of the GP, consistent with the plan. Useful for periodic medication list reconciliation and DAA review.
Care plan tips →
🤝
Setting up a DAA — practical steps
›
Suggested workflow
  1. Confirm indication and rule out alternatives (simpler regimen, reminder alarm, carer supervision)
  2. If polypharmacy or unclear adherence, consider HMR (Item 900) first to identify deprescribing opportunities
  3. Provide the patient's community pharmacy with a current, reconciled medication list — mark PRN vs regular clearly
  4. Note any medicines that must NOT be packed (see previous tab) so pharmacy can plan alternatives
  5. Document the DAA in your practice software so future scripts are reviewed with packing in mind
  6. Schedule a review at 1 month to confirm adherence and any issues with the pack contents
💡 The pharmacy usually takes 1–2 days to prepare the first pack. Advise the patient to keep taking their current supply until the pack is ready.
🔄
Managing changes during packing
›
When you change a script
  • Notify the packing pharmacy — either directly, via patient, or on the script itself (e.g. "for Webster pack")
  • Advise the patient not to add new tablets to the existing pack — wait for the next re-pack
  • If change is urgent, ask the pharmacy to re-pack or provide interim supply outside the pack
When dose changes but tablet strength stays the same e.g. metformin 500mg BD → TDS: pharmacy typically re-packs. If change happens mid-week, patient may need loose supply to bridge.
Antibiotic courses Short courses are usually dispensed separately (not in the weekly pack) with clear labelling on when to start and when to stop.
⚠️ Deprescribing rarely happens by accident. A stable Webster pack can quietly perpetuate polypharmacy for years. Schedule medication reviews at least annually — the HMR/RMMR pathway is designed for this.
🏠
Discharge from hospital — Webster pack transitions
›
Common scenarios
  • Discharge with a changed regimen but the patient's existing pack still has the old medicines — real risk of double-dosing or missed doses
  • Hospital pharmacy provides an interim supply; community pharmacy re-packs at first script
  • Patient may need a bridging appointment within 1–2 weeks to confirm the new regimen is reflected in the pack
💡 If discharge summary lists new or ceased medicines, phone or fax the packing pharmacy directly rather than relying on the patient to communicate the change.
Patient-facing: My Medication List →
ℹ️ Reference only. Not a substitute for MBS Online, the Pharmacy Programs Administrator DAA Program Rules, or PSA standards. Verify current MBS item descriptors, DAA Program eligibility, and PBS listings before advising patients or claiming services. Fees are MBS schedule fees valid from 1 July 2026 — actual rebates depend on billing method. This page summarises publicly available information for GP quick reference. Sources: MBS Book (March 2026, indexed July 2026), MBS Online, Pharmacy Programs Administrator, PSA. Last reviewed July 2026.